Ordinary Adjustment | Solactive Genomics Index | Effective Date 11th November 2024
Solactive Genomics v2 Index:
In the ordinary adjustment, the following composition will be implemented effective open 11th November 2024:
VERTEX PHARMACEUTICALS INC |
GILEAD SCIENCES INC |
AGILENT TECHNOLOGIES INC |
ALNYLAM PHARMACEUTICALS INC |
BIONTECH SE |
ILLUMINA INC |
MODERNA INC |
NATERA INC |
BIOMARIN PHARMACEUTICAL INC |
SAREPTA THERAPEUTICS INC |
BIO-TECHNE CORP |
QIAGEN NV |
LEGEND BIOTECH CORP |
AVIDITY BIOSCIENCES INC |
ULTRAGENYX PHARMACEUTICAL INC |
CRISPR THERAPEUTICS AG |
VERACYTE INC |
ARROWHEAD PHARMACEUTICALS INC |
INTELLIA THERAPEUTICS INC |
MYRIAD GENETICS INC |
GENSCRIPT BIOTECH CORP |
BEAM THERAPEUTICS INC |
10X GENOMICS INC |
ROCKET PHARMACEUTICALS INC |
CAREDX INC |
MARAVAI LIFESCIENCES HOLDINGS INC |
VIR BIOTECHNOLOGY INC |
SANA BIOTECHNOLOGY INC |
PACIFIC BIOSCIENCES OF CALIFORNIA INC |
REGENXBIO INC |
ALLOGENE THERAPEUTICS INC |
FULGENT GENETICS INC |
VERVE THERAPEUTICS INC |
SANGAMO THERAPEUTICS INC |
UNIQURE B.V. |
EDITAS MEDICINE INC |
2SEVENTY BIO INC-W/I |
POSEIDA THERAPEUTICS INC |
CARIBOU BIOSCIENCES INC |
LYELL IMMUNOPHARMA INC |